Health TrialsbyHealthPanel

Recurrent Urinary Tract Infection

4

Review clinical trials related to Recurrent Urinary Tract Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections

A randomized, double-blind, placebo-controlled, 12-month study to determine the effectiveness of D-mannose (2g daily) supplementation in rUTI (recurrent urinary tract infection) prevention in post-menopausal women.

Participants needed: 90
Trial details
Age: 55-85Biological sex: FemaleType: InterventionalSponsor: University of Texas Southwestern Medical CenterUpdated: Sep 22, 2025Locations: 1
Eligibility criteria

Female, post-menopausal, age ≥ 55 years old [+4]

Current use of D-mannose. Patients willing to stop taking D-mannose will be offe... [+23]

Read more
Status: Recruiting

Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study

The GT RACING is a study comparing the efficacy of HA-CS bladder installations with prophylactic antibiotics in the prevention of recurrent urinary tract infections (rUTI).

Participants needed: 100
Trial details
Phase: Phase 4Age: 18+Biological sex: FemaleType: InterventionalSponsor: Radboud University Medical CenterUpdated: Nov 18, 2024Locations: 3
Eligibility criteria

Adult female patients (>18 years) who had at least 3 symptomatic UTI's in the pr... [+1]

Male [+25]

Read more
Status: Recruiting

Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.

Participants needed: 100
Trial details
Phase: Phase 2, Phase 3Age: 18-90Biological sex: FemaleType: InterventionalSponsor: Helsinki University Central HospitalUpdated: Sep 22, 2023Locations: 1
Eligibility criteria

Female subjects aged ≥18 [+2]

Suspected non-compliance [+5]

Read more
Status: Recruiting

The Effect of ASTARTE™ on Recurrent Urinary Tract Infection

Investigate the effect of dietary supplements/probiotic ASTARTE™ ( L. crispatus, L. rhamnosus, L. jensenii, L. gasseri) on the microbiome composition in the intestine and vagina and thereby a reduction of risk factors for the development of rUTI during 6 months of intervention in women aged 18-40 years. This is measured by the incidence of symptomatic UTI.

Participants needed: 720
Trial details
Age: 18-40Biological sex: FemaleType: InterventionalSponsor: Hvidovre University HospitalUpdated: Sep 23, 2022Locations: 1
Eligibility criteria

Women 18-40 years of age [+3]

Pregnancy or planning pregnancy [+5]

Read more